Glaxo Sales, Shares Benefit From Brexit Effects on Pound: Chart

GlaxoSmithKline Plc has gotten stronger as the British pound has gotten weaker. The U.K.’s biggest drugmaker gets the largest single chunk of its sales from the U.S., and the company can now convert those dollars into pounds at a more favorable rate. The London-based company will report quarterly results Wednesday.

    Before it's here, it's on the Bloomberg Terminal.
    LEARN MORE